RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for vulnerable patients: remdesivir trial targets RSV in Immune-Weakened individuals
Disease control Recruiting nowThis study tests if the antiviral drug remdesivir can safely treat RSV (a common respiratory virus) in 60 adults whose immune systems are weakened by cancer treatments or autoimmune therapies. Participants must have a confirmed RSV infection with symptoms. The main goal is to see…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New RSV pill for babies shows promise in major trial
Symptom relief Recruiting nowThis study tests an oral medicine called deurremidevir hydrobromide in infants and young children (1 month to 3 years old) with RSV infection. About 498 children will receive either the medicine or a placebo for 5 days. The goal is to see if the medicine helps relieve RSV symptom…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 17, 2026 04:33 UTC
-
RSV study targets elderly hospital patients in vietnam
Knowledge-focused Recruiting nowThis study looks at how common RSV (a respiratory virus) is in adults aged 60 and older who are hospitalized in Vietnam for breathing problems or worsening heart/lung conditions. Researchers will test samples from the nose or throat to confirm RSV and track its severity. The goal…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC